RIHAWI, KARIM
 Distribuzione geografica
Continente #
NA - Nord America 613
EU - Europa 547
AS - Asia 177
AF - Africa 49
Totale 1.386
Nazione #
US - Stati Uniti d'America 611
IT - Italia 210
GB - Regno Unito 76
VN - Vietnam 69
CN - Cina 64
SE - Svezia 64
DE - Germania 59
IE - Irlanda 40
IN - India 28
TG - Togo 27
BE - Belgio 19
BG - Bulgaria 18
CH - Svizzera 15
FR - Francia 15
JO - Giordania 10
CI - Costa d'Avorio 9
EE - Estonia 7
UA - Ucraina 7
ZA - Sudafrica 7
FI - Finlandia 6
NG - Nigeria 6
RU - Federazione Russa 6
HK - Hong Kong 5
NL - Olanda 2
AT - Austria 1
CA - Canada 1
CZ - Repubblica Ceca 1
GR - Grecia 1
PA - Panama 1
UZ - Uzbekistan 1
Totale 1.386
Città #
Chandler 85
Fairfield 68
Southend 67
Bologna 57
Ashburn 56
Houston 45
Woodbridge 44
Dublin 40
Seattle 37
Dong Ket 34
Wilmington 29
Princeton 28
Lomé 27
Cambridge 23
Brussels 19
Florence 19
Sofia 18
Vicenza 18
Bern 15
Amman 10
Turin 10
Abidjan 9
Redmond 9
Bremen 8
Jinan 8
New York 8
Westminster 8
Ann Arbor 7
Beijing 7
Berlin 7
Forlì 7
Nanjing 7
Abeokuta 6
Shanghai 6
Hebei 5
Helsinki 5
Milan 5
San Diego 5
Boydton 4
Falls Church 4
Rome 4
Shenyang 4
Tianjin 4
Carpi 3
Changsha 3
Medford 3
Naples 3
Padova 3
Paris 3
Redwood City 3
Cesena 2
Dearborn 2
Des Moines 2
Formigine 2
Groningen 2
Hangzhou 2
Hong Kong 2
Imola 2
Ithaca 2
Kilburn 2
Los Angeles 2
Messina 2
Modena 2
Montelupone 2
Mülheim 2
Pescara 2
Prescot 2
Pune 2
Bassano Del Grappa 1
Bedford 1
Castel San Pietro Terme 1
Castenaso 1
Castiglione dei Pepoli 1
Chicago 1
Clearwater 1
Cogollo del Cengio 1
Costa Mesa 1
Fuzhou 1
Guangzhou 1
Jiaxing 1
Kato Synoikia Trikalon 1
Kunming 1
Lana 1
Lanzhou 1
Lappeenranta 1
Las Vegas 1
London 1
Lyon 1
Martignacco 1
Monza 1
Nanchang 1
Ningbo 1
Norwalk 1
Panama City 1
Perugia 1
Pewsey 1
Phoenix 1
Podenzano 1
Recanati 1
Reggio Emilia 1
Totale 975
Nome #
Arterial Embolization During Programmed Death-1 Inhibitor Treatment: An Unexpected Finding 132
A streamlined workflow for single-cells genome-wide copy-number profiling by low-pass sequencing of LM-PCR whole-genome amplification products. 119
Pembrolizumab in the treatment of metastatic non-small cell lung cancer: A review of current evidence 117
Co-alteration of c-Met and ROS1 in Advanced NSCLC: ROS1 Wins 109
A phase II, open-label, single arm, trial of carboplatin plus etoposide with bevacizumab and atezolizumab in patients with extended-stage small-cell lung cancer (CeLEBrATE study): background, design and rationale 107
MYC Amplification as a Potential Mechanism of Primary Resistance to Crizotinib in ALK-Rearranged Non-Small Cell Lung Cancer: A Brief Report 106
Roles of IL-1 in Cancer: From Tumor Progression to Resistance to Targeted Therapies 104
Chemotherapy treatment in malignant pleural mesothelioma: A difficult history 99
BRAF Mutant NSCLC and Immune Checkpoint Inhibitors: Results From a Real-World Experience 87
Reliability of programmed death ligand 1 (PD-L1) tumor proportion score (TPS) on cytological smears in advanced non-small cell lung cancer: a prospective validation study 71
Expected and non-expected immune-related adverse events detectable by CT 64
Automated Prediction of the Response to Neoadjuvant Chemoradiotherapy in Patients Affected by Rectal Cancer 60
Emerging therapies in malignant pleural mesothelioma 54
Pneumatosis intestinalis and spontaneous perforation associated with drug toxicity in oncologic patients: A case series 50
The autocrine loop of ALK receptor and ALKAL2 ligand is an actionable target in consensus molecular subtype 1 colon cancer 48
Tumor-associated macrophages and inflammatory microenvironment in gastric cancer: Novel translational implications 39
IL-1 Associated Post Senescence Reprogramming Impairs Response To EGFR Neutralization 36
Novel HER2-directed treatments in advanced gastric carcinoma: Another paradigm shift? 34
The safety and efficacy of enzalutamide in the treatment of advanced prostate cancer 14
Immune checkpoint inhibition in small cell lung cancer: A key to reach an unmet need? 9
Totale 1.459
Categoria #
all - tutte 3.918
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.918


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201917 0 0 0 0 0 0 0 4 0 7 0 6
2019/2020267 42 3 0 22 27 21 33 34 40 13 17 15
2020/2021241 23 25 25 0 26 6 12 8 13 9 15 79
2021/2022221 7 2 7 4 17 16 5 27 16 19 60 41
2022/2023552 21 54 12 56 49 68 36 36 92 14 69 45
2023/2024146 18 24 16 16 21 40 5 6 0 0 0 0
Totale 1.459